Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis ; volume:21 ; number:1 ; day:1 ; month:6 ; year:2023 ; pages:1-12 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (1.6.2023), 1-12, 12.2023
- Urheber
-
Ma, Yongli
Li, Jinghui
Wen, Liang
Zhang, Guosheng
Yao, Xueqing
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-03055-0
- URN
-
urn:nbn:de:101:1-2023091308285337219989
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Yongli
- Li, Jinghui
- Wen, Liang
- Zhang, Guosheng
- Yao, Xueqing
- SpringerLink (Online service)
Ähnliche Objekte (12)
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
ASO Visual Abstract: Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
ASO Visual Abstract: Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
ASO Visual Abstract: Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer